Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older Adults (EngAGE) (NCT05337514)
Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older Adults: EngAGEing Older Adult-Care Partner Dyads
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to test the efficacy of EngAGE (an interactive, voice-activated app) vs usual care on improving older adult physical and social function.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (6 items) and avoid the listed exclusions (9 items).
Location: University of Chicago — Chicago, Illinois
Age range: 60 Years
🧪 Interventions in This Study
- Enhanced Engagement (BEHAVIORAL)
- Standard Engagement (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- reported history of moderate to advanced cognitive impairment;
- inability to stand unassisted;
- inability to understand English (because the intervention is currently only available in English);
- life expectancy less than 12 months or enrolled in Hospice;
- a medical condition making unsupervised physical activity potentially unsafe including: stroke within prior 12 months, acute myocardial infarction or unstable angina in the prior 6 months, uncontrolled arrhythmias, dissecting aortic aneurysm, acute endo/pericarditis, acute thromboembolism, acute or severe heart or respiratory failure, uncontrolled hypertension greater than 180/100, fracture or joint replacement within the prior 3 months, infections affecting one's general health condition, severe peripheral vascular disease.
- severe functional impairment as indicated by an SPPB score less than 3 (out of 12);
- baseline Montreal Cognitive Assessment of less than or equal to 18/30;
- inability to understand consent (teach back).
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- University of Chicago — Chicago, Illinois
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Frailty
- A Study of Human Allogeneic Bone-marrow-derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Aging Frailty — Nassau,
- Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty — St John's,
- Frailty Rehabilitation — Hamilton, Ontario
- High Intensity Interval Training (HIIT) to Reduce Frailty and Enhance Resilience in Older Veterans — Kansas City, Missouri
- Meal Delivery and Exercise — Houston, Texas
- SCM Muscle as a Marker for Frailty in Patients Undergoing ENT Surgery — New York, New York
Explore by condition: All Frailty clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.